Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 May;9(5):471–478. doi: 10.1111/j.1365-2125.1980.tb05842.x

Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.

J Perez, D S Sitar, R I Ogilvie
PMCID: PMC1429944  PMID: 7397063

Abstract

The kinetic disposition and diuretic effect of frusemide was assessed in 16 patients with acute pulmonary oedema utilizing a specific gas-liquid chromatographic assay for the drug. Serum frusemide concentrations decayed biexponentially with wide variation in both alpha half-life (range 15-79 min) and beta half-life (range 127-1190 min). The beta phase half-life was inversely related to creatine clearance. The apparent volume of distribution varied greatly among the patients (range 0.085-0.818 l/kg), and patients with an acute myocardial infarction had a larger peripheral kinetic compartment. Patients with acute myocardial infarction excreted less unchanged drug and had a lesser urinary excretion of sodium and volume compared to patients without infarction. The urinary excretion of sodium, chloride, calcium and volume was linearly related to the urinary excretion of unchanged frusemide.

Full text

PDF
476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberman A., Fulop M. The metabolic and respiratory acidosis of acute pulmonary edema. Ann Intern Med. 1972 Feb;76(2):173–184. doi: 10.7326/0003-4819-76-2-173. [DOI] [PubMed] [Google Scholar]
  2. Allison M. E., Kennedy A. C. Diuretics in chronic renal disease: a study of high dosage frusemide. Clin Sci. 1971 Sep;41(3):171–187. doi: 10.1042/cs0410171. [DOI] [PubMed] [Google Scholar]
  3. Andreasen F., Hansen H. E., Mikkelsen E. Pharmacokinetics of furosemide in anephric patients and in normal subjects. Eur J Clin Pharmacol. 1978 Mar 17;13(1):41–48. doi: 10.1007/BF00606681. [DOI] [PubMed] [Google Scholar]
  4. Andreasen F., Mikkelsen E. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol. 1977 Aug 17;12(1):15–22. doi: 10.1007/BF00561400. [DOI] [PubMed] [Google Scholar]
  5. Beermann B., Dalén E., Lindström B., Rosén A. On the fate of furosemide in man. Eur J Clin Pharmacol. 1975 Oct 10;9(1):51–61. doi: 10.1007/BF00613429. [DOI] [PubMed] [Google Scholar]
  6. Branch R. A., Roberts C. J., Homeida M., Levine D. Determinants of response to frusemide in normal subjects. Br J Clin Pharmacol. 1977 Apr;4(2):121–127. doi: 10.1111/j.1365-2125.1977.tb00682.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burg M., Stoner L., Cardinal J., Green N. Furosemide effect on isolated perfused tubules. Am J Physiol. 1973 Jul;225(1):119–124. doi: 10.1152/ajplegacy.1973.225.1.119. [DOI] [PubMed] [Google Scholar]
  8. Calesnick B., Christensen J. A., Richter M. Absorption and excretion of furosemide-S35 in human subjects. Proc Soc Exp Biol Med. 1966 Oct;123(1):17–22. doi: 10.3181/00379727-123-31391. [DOI] [PubMed] [Google Scholar]
  9. Cutler R. E., Forrey A. W., Christopher T. G., Kimpel B. M. Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clin Pharmacol Ther. 1974 Jun;15(6):588–596. doi: 10.1002/cpt1974156588. [DOI] [PubMed] [Google Scholar]
  10. Fuller R. K., Khambatta P. B., Gobezie G. C. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide. JAMA. 1977 Mar 7;237(10):972–975. [PubMed] [Google Scholar]
  11. Huang C. M., Atkinson A. J., Jr, Levin M., Levin N. W., Quintanilla A. Pharmacokinetics of furosemide in advanced renal failure. Clin Pharmacol Ther. 1974 Oct;16(4):659–666. doi: 10.1002/cpt1974164659. [DOI] [PubMed] [Google Scholar]
  12. Lawrence J. R., Ansari A. F., Elliott H. L., Sumner D. J., Brunton G. F., Whiting B., Whitesmith R. Kinetic and dynamic comparison of piretanide and furosemide. Clin Pharmacol Ther. 1978 May;23(5):558–565. doi: 10.1002/cpt1978235558. [DOI] [PubMed] [Google Scholar]
  13. Le Gall J. R., Raphaël J. C., Offenstadt G., Marcel G. A., Mignon F., Métreau J. M., Bader J. P., Rapin M. Traitement d'un cas d'hypercalcémie aiguë par le furosémide. Ann Med Interne (Paris) 1971 May;122(5):613–617. [PubMed] [Google Scholar]
  14. Lesch M., Caranasos G. J., Mulholland J. H. Controlled study comparing ethacrynic acid to mercaptomerin in the treatment of acute pulmonary edema. N Engl J Med. 1968 Jul 18;279(3):115–122. doi: 10.1056/NEJM196807182790301. [DOI] [PubMed] [Google Scholar]
  15. Muth R. G. Diuretic properties of furosemide in renal disease. Ann Intern Med. 1968 Aug;69(2):249–261. doi: 10.7326/0003-4819-69-2-249. [DOI] [PubMed] [Google Scholar]
  16. Perez J., Sitar D. S., Ogilvie R. I. Biotransformation of furosemide in patients with acute pulmonary edema. Drug Metab Dispos. 1979 Nov-Dec;7(6):383–387. [PubMed] [Google Scholar]
  17. Rane A., Villeneuve J. P., Stone W. J., Nies A. S., Wilkinson G. R., Branch R. A. Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clin Pharmacol Ther. 1978 Aug;24(2):199–207. doi: 10.1002/cpt1978242199. [DOI] [PubMed] [Google Scholar]
  18. Rose H. J., Pruitt A. W., Dayton P. G., McNay J. L. Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia. J Pharmacol Exp Ther. 1976 Dec;199(3):490–497. [PubMed] [Google Scholar]
  19. Suki W. N., Yium J. J., Von Minden M., Saller-Hebert C., Eknoyan G., Martinez-Maldonado M. Acute treatment of hypercalcemia with furosemide. N Engl J Med. 1970 Oct 15;283(16):836–840. doi: 10.1056/NEJM197010152831603. [DOI] [PubMed] [Google Scholar]
  20. Toft H., Roin J. Furosemids virkning på calciumekskretionen i urinen. Nord Med. 1970 Nov 5;84(45):1431–1433. [PubMed] [Google Scholar]
  21. Walser M. Treatment of hypercalcemias. Mod Treat. 1970 May;7(3):662–674. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES